This episode of the IAH podcast is actually a double dipping orgasmic sonic podcast co-share with the MAPS Podcast (www.maps.opg). The interview with Duncan was so good, of course, that I felt compelled to use it for both shows that I host. What can be said about a talk with Duncan? Not much that hasn’t been said before however, since this episode was recorded for the MAPS show it’s focus is primarily on psychedelics. Duncan is one of the smartest psychonauts in the multi-verse and is no doubt one of the finest representatives for the power and potential of psychedelics. Enjoy!
INTRO RANT – On John Perry Barlow
This episode of the podcast is brought to you by The Timothy Leary Project a new book by Jennifer Ulrich, published by Abrams Books.
Duncan Trussell is a comedian, psychonaut and host of the wildly popular Duncan Trussell Family Hour
Have you wondered what happens on a neuro-scientific and physiological level when phsychedelics enter your body? That question has been at the root of the psychedelic experience for generations if not centuries. Ancient mystics had the understnading that these sacred plant medicines contained tribal DNA which was necessary to keep cultures and history alive. However, now that we have more data and research available we can augment that thinking with actual stuides that illustrate how the brain is effected when these agents enter our system.
Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization. Additionally, he will report the effects of both drugs on brain and subjective responses to personal autobiographical memory cues.
Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.
In 2005, Robin began a four year PhD in Psychopharmacology at the University of Bristol. In 2009, he successfully coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years. Also in 2009, Robin moved to Imperial College London to continue his work under the supervision of Professor David Nutt. Robin has since coordinated the first resting state fMRI and MEG investigations of a psychedelic drug and the first fMRI study of MDMA in the UK. Robin and David Nutt recently received ethics approval for an MRC-sponsored clinical trial that will investigate the efficacy of psilocybin as a treatment for depression and an LSD fMRI and MEG study. Robin’s work is published in PNAS, Brain, Schizophrenia Bulletin and the British Journal of Psychiatry and he has appeared in television interviews for BBC news and Channel 4.
I’m so thrilled, honored and humbled to announce that the MAPS (Multidisciplinary Association for Psychedelic Studies) Podcast is now live. It’s been in the works for some time and took a little crafting to get it just right. Myself and the good people at MAPS are finally ready to release it to the world!
The intention of the podcast is to take the very rich and valuable MAPS audio archives and to curate them in a way that can target not only researchers but also the general public that is looking to learn more about the vast landscape of modern psychedelic research. Some episodes will feature some of the great talks by many of the great minds that have spoken at past Psychedelic Science conferences, breakout panels and keynote speeches while others will be original content that tap some of the great modern luminaries, scientists, journalists and even comedians.
My role, as the host, is to give each episode context and flavor stemming from my life long admiration and association for the community, the research and culture. Without getting into too much personal melo-drama (because the podcast is not about me) I do want to say that I am very humbled to be able to contribute to this community in any sort of official capacity. I spent many years keeping a distance because of the ever looming presence and brilliance of my dads work. Being too close to it simply felt too nerve racking and not authentic to my own path. Time does pass and it’s afforded me wisdom in the form of being granted confidence in my own voice and knowing exactly what I have to offer. With that, I am beyond excited to find a little niche that works for me.
Thank you to the MAPS family for including me in this adventure!
These two episodes are now available:
Episode 1 – James Fadiman, Scientific Problem Solving with Psychedelics
Episode 2 – Stephen Ross, MD – Psilocybin, Addiction and End of Life Anxiety
To listen and subscribe on iTunes please click here
To get more information on MAPS please visit their site at www.maps.org
I’m thrilled beyond measure to announce a new project that I’ll be involved with. Starting in late January I’ll be hosting the all-new MAPS (maps.org) podcast simply called “The MAPS Podcast”.
It will feature classic lectures and panels from many of the sensational past Psychedelic Science conferences, treasures from the Rick Doblin archives as well as all new interviews and content made just for this.
I’m honored to be a part of it and hope that I can help steer the podcast into the high-quality show that it deserves to be. Thank you to Brad Burge, Matt Neal and Rick Doblin for having me involved. God speed!
Rick and I explore the multi-verse, MAPS 30th Anniversary and the complicated, rewarding and revolutionary road that psychedelics has seen over the course of the last 50 years. Recorded off site at the University of Pennsylvania where Rick and I were both panelists at the BioEthics Film Conference. This is a podcast that I’ve been wanting to do since Day 1 and I’m thrilled that it came together.
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and three children.